Letters
Kobasa's hardiness theory and stress; Plastic connector hazard
Print version: 1987;55(1):3.

 

Guest Editorial
By Chuck Biddle, CRNA, MS
The evolution of a scholarly journal: Of readers, writers and gatekeepers.Print version: 1987;55(1):9-11.

 

Legal Briefs
By Gene A. Blumenreich, JD
The doctrine of Res Ipsa Loquitur
Print version: 1987;55(1):13-15.

 

Washington Scene
By Richard E. Verville, JD
The Agenda for the 100th Congress.
Print version: 1987;55(1):33-35.

 

By Kenneth A. Conklin, MD, PhD
This article focuses on the pharmacology of local anesthetics in common clinical usage, encompassing chemistry, pharmacodynamics, pharmacokinetics, systemic pharmacology, and toxicology.
Print version: 1987;55(1):36-44.

 

Sufentanil as a component of outpatient anesthesia
By Dorothy Williams, CRNA
F. Robert Weis, Jr., MD
Michael G. Adragna, MD
Bruce M. Nohejl, MD
The authors report on their study of 50 ASA I and II patients who received a combination of sufentanil, atracurium, thiamylal and nitrous oxide for outpatient anesthesia.
Print version: 1987;55(1):45-48.

 

A comparison of cocaine, oxymetazoline, and saline for nasotracheal intubation
By Franklin T. R. Rector, CRNA, MS, CCRN
David J. DeNuccio, PhD
Meigs A. Alden, CRNA, MEd
In this double-blind study of 36 patients, topical vasoconstrictive agents were compared to assess their effectiveness in decreasing the epistaxis associated with nasotracheal intubation.
Print version: 1987;55(1):49-54.

 

Hepatitis: Risks confronting nurse anesthetists
By Patricia A. ONeill, CRNA, BSN
The author reviews the various types of hepatitis and modes of transmission, with emphasis being placed on risk factors and preventative measures as they pertain to the nurse anesthetist.
Print version: 1987;55(1):55-58.

 

AANA Journal Course: Quality assurance- Part VI- FDA approval and surveillance of medical devices
By Ann A. Graham, CRNA
Part VI of this 1986-87 Journal Course on Quality Assurance is provided as an introduction to the regulatory and nonregulatory efforts of the FDA. Regulatory processes of device classification, pre-market notification and approval processes and educational programs are examined.
Print version: 1987;55(1):59-64.

 

By Reba Luhrs, CRNA, BSA
Ernie Fuller, MD
The authors present a case encountered in Haiti of a surgical patient with advanced tumors of the mandible and oral cavity.
Print version: 1987;55(1):81-82.

 

General and subscription Information
Print version: 1987;55(1):2.

 

Index to advertisers
Print version: 1987;55(1):88.